Michel Giunta
Participe à 1 Session
Sessions auxquelles Michel Giunta participe
3:35 PM
3:35 PM
- Treatment switch from aflibercept to ranibizumab in Canadian DME patients in a real-world setting: the PRECISE study 237
- Conférencier.ère Michel Giunta |
- 3:35 PM - 3:43 PM | 8 minutes Partie de: Rétine I
- Paper Presentation | Présentation d'article